(Press-News.org) Insilico Medicine founder and CEO Alex Zhavoronkov, PhD, a pioneer in generative AI for drug discovery and in uncovering dual pathways for aging and disease, will present at The Fourth Summit: Geroscience for the Next Generation organized by the Geroscience Interest Group of the National Institutes of Health (NIH) and the U.S. Department of Health and Human Services, happening April 24-26 at the NIH Main Campus in Bethesda, Maryland. Zhavoronkov will speak April 25, 1:40pm ET as part of the session on Mathematical Modeling of Aging and Health for Geroscience on “Selecting and Extracting Features Relevant to Aging.”
Insilico has focused on the intersection of aging and disease since its inception, and Zhavoronkov is a leading expert in the longevity space, and one of the founders of the Aging Research and Drug Discovery conference. When deep neural networks (DNNs) – the drivers of artificial intelligence (AI) – began outperforming humans in the mid-2000s, the Company began training DNNs on human “multi-omics” data and then retraining them on disease.
“DNNs gave us the ability to generate massive synthetic data with age as a generation condition,” says Zhavoronkov. “And we could use these DNNs to better understand human disease and aging biology.”
The Company went on to build an end-to-end AI-driven drug discovery platform called Pharma.AI that includes target discovery (PandaOmics), drug design (Chemistry42), and clinical trial prediction (InClinico). In 2022, Insilico used this platform to identify 145 aging-related therapeutic targets across diseases including Alzheimer’s, Parkinson’s, and osteoarthritis, which were further narrowed into 9 promising dual aging and disease targets. The results were published in the journal Aging. Insilico’s lead therapeutic candidate, for the devastating aging-related lung disease idiopathic pulmonary fibrosis, has received positive topline results in Phase 1 clinical trials and Orphan Drug Designation from the FDA.
Geroscience, the study of interventions to delay or stop the functional decline associated with aging-related diseases, is a rapidly growing field. One of the field’s major challenges is how to measure overall health and rates of aging – to accurately assess the conditions or interventions that slow or accelerate aging, especially in the context of clinical outcomes. Utilizing mathematical modeling and AI can provide key insights.
“The acceleration of AI technology has had significant impact on aging and longevity research,” says Zhavoronkov. “First, we were able to identify biomarkers for aging. Now, we are using those insights to transform the entire drug discovery process.”
About Insilico Medicine:
Insilico Medicine, a clinical-stage end-to-end generative artificial intelligence (AI)-driven drug discovery company, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques to discover novel targets and design novel molecular structures with desired properties. Insilico Medicine is delivering breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system (CNS) diseases, and aging-related diseases. www.insilico.com
END
Using AI to address aging and disease: Insilico Medicine’s Alex Zhavoronkov, PhD presents at the Geroscience Summit
2023-04-03
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
A sensor that might someday enable ‘mind-controlled’ robots
2023-04-03
It sounds like something from science fiction: Don a specialized, electronic headband and control a robot using your mind. But now, recent research published in ACS Applied Nano Materials has taken a step toward making this a reality. By designing a special, 3D-patterned structure that doesn’t rely on sticky conductive gels, the team has created “dry” sensors that can measure the brain’s electrical activity, even amidst hair and the bumps and curves of the head.
Physicians monitor electrical signals ...
Older adults perceive artificial intelligence as more human-like than younger adults do
2023-04-03
Older adults perceive artificial intelligence as more human-like than younger adults do
Toronto, April 3, 2023 – Artificial intelligence (AI) is increasingly present in all of our lives, from newer offerings like ChatGPT to more established voice systems such as automated phone services, self-checkouts, Apple’s Siri and Amazon’s Alexa. While these technologies largely benefit us, they can also be used in adverse ways – for instance, in fraudulent or scam calls – making it important for us to be able to identify them.
According to a recent Baycrest study, older adults appear to be less able to distinguish ...
E-health reduces patient pain, opioids in clinical study
2023-04-03
SPOKANE, Wash. – An online “e-health” program helped more people with chronic pain reduce their opioid medications and pain intensity than a control group that had only regular treatment in a recent clinical study.
In the study published in the journal Pain, about 400 participants who had been prescribed long-term opioid treatment for their pain were divided into two groups: one received treatment as usual and another received treatment and access to a self-guided, e-health program. Of the e-health group, more than half, 53.6%, were able to reduce their ...
Purified curcumin instead of artificial additives can be used to preserve and enhance probiotic yogurt
2023-04-03
Researchers have succeeded for the first time in adding a highly purified form of curcumin to yogurt in a way that ensures it remains dissolved in the dairy product and preserves it, while tasting good.
Their discovery, which is published today (Monday) in Frontiers in Nutrition, makes it possible to create a probiotic yogurt that contains no artificial preservatives but that still has a long shelf life and properties that may enhance good health.
Curcumin is a naturally-occurring chemical that provides the yellow colour in turmeric. Studies have shown that it has anti-inflammatory and anti-oxidative properties, that it can inhibit the growth ...
English language pushes everyone – even AI chatbots - to improve by adding
2023-04-03
A linguistic bias in the English language that leads us to ‘improve’ things by adding to them, rather than taking away, is so common that it is even ingrained in AI chatbots, a new study reveals.
Language related to the concept of ‘improvement’ is more closely aligned with addition, rather than subtraction. This can lead us to make decisions which can overcomplicate things we are trying to make better.
The study is published today (Monday 3rd April) in Cognitive Science, by an international ...
Privately sponsored refugees likely to receive better prenatal care than government-assisted refugees in Canada
2023-04-03
Government-assisted refugees were less likely to receive adequate prenatal care than privately sponsored refugees, found a new study published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221207.
Canada has 2 main pathways to resettle refugees: government assistance and private sponsorship by family members or non-family volunteers.
To determine whether refugees receive adequate prenatal care (defined as initiation of prenatal care by 13 weeks' gestation; receipt of a minimum number of prenatal care visits, as recommended by the Society of Obstetricians and Gynaecologists of Canada; and receipt of a prenatal fetal anatomy ultrasound ...
Taylor & Francis to pilot first transparent peer review model for a higher education research journal
2023-04-03
The quality and integrity of peer review in Higher Education research has been put firmly in the spotlight by the European Journal of Higher Education (EJHE), published by Taylor & Francis. All articles submitted from April 2023 will, if accepted, have their reviewer reports published at the same time, as part of a one-year pilot.
The EJHE peer review process itself will remain the same, with reports on manuscripts under consideration received from two or three referees before an editorial decision is made. ...
Virginia Tech researcher identifies narrow opportunity to address a rare disease linked to autism, schizophrenia
2023-04-03
The human brain begins to assemble itself shortly after conception as a growing number of brain cells connect to create circuits across the brain.
Genes provide the blueprint for construction, but occasionally the blueprint is incomplete, connections aren’t made, and circuits fail — sometimes long before the problem can be recognized, let alone fixed.
That’s the case with DiGeorge syndrome, also called 22q11.2 deletion syndrome, a genetic disorder affecting about one in 3,000 babies. It begins with a deletion of one of two copies of a small number of genes on human chromosome 22, whose cascading effects include cardiovascular problems, craniofacial ...
Polyamorous relationships can have as many benefits as monogamous ones, shows research
2023-04-03
Polyamorists face stigma and discrimination in their day-to-day lives, yet research shows that having a romantic relationship with more than one person at a time may offer emotional and physical benefits to all parties.
Monogamy is frequently portrayed as the ideal form of romantic love in many modern societies. From the stories we read as children, to the films and books we consume as adults – we are told that to achieve happiness we need to find our one true soulmate to share the rest of our lives with.
At the same time, states and governments offer financial, legal, and social incentives to married couples. Meanwhile men and women who deviate from these monogamous ...
Aston University establishes new independent investment company
2023-04-02
Aston University is one of eight research intensive universities in the Midlands to establish a new investment company to accelerate the commercialisation of university spinouts and early-stage IP rich businesses in the region.
Midlands Mindforge Limited has been co-founded by Aston University, University of Birmingham, Cranfield University, Keele University, University of Leicester, Loughborough University, University of Nottingham and University of Warwick, collectively Midlands Innovation.
This ambitious, patient capital ...